Menu

Blog

Apr 8, 2024

Harvard and MIT Scientists Discover Cholesterol-Busting Microbes in the Gut

Posted by in category: biotech/medical

Alterations in the gut microbiome are associated with a range of diseases, such as type 2 diabetes, obesity, and inflammatory bowel disease.

Now, a team of researchers at the Broad Institute of MIT and Harvard along with Massachusetts General Hospital has found that microbes in the gut may affect cardiovascular disease as well. In a study published in Cell, the team has identified specific species of bacteria that consume cholesterol in the gut and may help lower cholesterol and heart disease risk in people.

Members of Ramnik Xavier’s lab, Broad’s Metabolomics Platform, and collaborators analyzed metabolites and microbial genomes from more than 1,400 participants in the Framingham Heart Study, a decades-long project focused on risk factors for cardiovascular disease.

Comments are closed.